SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-025598
Filing Date
2024-06-28
Accepted
2024-06-28 16:01:23
Documents
14
Period of Report
2024-06-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 63908
2 ex3-1.htm EX-3.1 9427
  Complete submission text file 0001493152-24-025598.txt   251851

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cocp-20240625.xsd EX-101.SCH 3036
4 XBRL LABEL FILE cocp-20240625_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cocp-20240625_pre.xml EX-101.PRE 22373
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3703
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 241085478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)